RESUMEN
OBJECTIVES: Clinical chorioamnionitis at term is considered the most common infection-related diagnosis in labor and delivery units worldwide. The syndrome affects 5-12% of all term pregnancies and is a leading cause of maternal morbidity and mortality as well as neonatal death and sepsis. The objectives of this study were to determine the (1) amniotic fluid microbiology using cultivation and molecular microbiologic techniques; (2) diagnostic accuracy of the clinical criteria used to identify patients with intra-amniotic infection; (3) relationship between acute inflammatory lesions of the placenta (maternal and fetal inflammatory responses) and amniotic fluid microbiology and inflammatory markers; and (4) frequency of neonatal bacteremia. METHODS: This retrospective cross-sectional study included 43 women with the diagnosis of clinical chorioamnionitis at term. The presence of microorganisms in the amniotic cavity was determined through the analysis of amniotic fluid samples by cultivation for aerobes, anaerobes, and genital mycoplasmas. A broad-range polymerase chain reaction coupled with electrospray ionization mass spectrometry was also used to detect bacteria, select viruses, and fungi. Intra-amniotic inflammation was defined as an elevated amniotic fluid interleukin-6 (IL-6) concentration ≥2.6 ng/mL. RESULTS: (1) Intra-amniotic infection (defined as the combination of microorganisms detected in amniotic fluid and an elevated IL-6 concentration) was present in 63% (27/43) of cases; (2) the most common microorganisms found in the amniotic fluid samples were Ureaplasma species, followed by Gardnerella vaginalis; (3) sterile intra-amniotic inflammation (elevated IL-6 in amniotic fluid but without detectable microorganisms) was present in 5% (2/43) of cases; (4) 26% of patients with the diagnosis of clinical chorioamnionitis had no evidence of intra-amniotic infection or intra-amniotic inflammation; (5) intra-amniotic infection was more common when the membranes were ruptured than when they were intact (78% [21/27] vs. 38% [6/16]; p=0.01); (6) the traditional criteria for the diagnosis of clinical chorioamnionitis had poor diagnostic performance in identifying proven intra-amniotic infection (overall accuracy, 40-58%); (7) neonatal bacteremia was diagnosed in 4.9% (2/41) of cases; and (8) a fetal inflammatory response defined as the presence of severe acute funisitis was observed in 33% (9/27) of cases. CONCLUSIONS: Clinical chorioamnionitis at term, a syndrome that can result from intra-amniotic infection, was diagnosed in approximately 63% of cases and sterile intra-amniotic inflammation in 5% of cases. However, a substantial number of patients had no evidence of intra-amniotic infection or intra-amniotic inflammation. Evidence of the fetal inflammatory response syndrome was frequently present, but microorganisms were detected in only 4.9% of cases based on cultures of aerobic and anaerobic bacteria in neonatal blood.
Asunto(s)
Líquido Amniótico , Bacteriemia , Corioamnionitis , Gardnerella vaginalis/aislamiento & purificación , Interleucina-6/análisis , Ureaplasma/aislamiento & purificación , Adulto , Líquido Amniótico/inmunología , Líquido Amniótico/microbiología , Bacteriemia/diagnóstico , Bacteriemia/etiología , Bacteriemia/microbiología , Bacteriemia/prevención & control , Biomarcadores/análisis , Corioamnionitis/diagnóstico , Corioamnionitis/epidemiología , Corioamnionitis/inmunología , Corioamnionitis/microbiología , Estudios Transversales , Femenino , Enfermedades Fetales/sangre , Enfermedades Fetales/diagnóstico , Humanos , Recién Nacido , Sepsis Neonatal/etiología , Sepsis Neonatal/prevención & control , Placenta/inmunología , Placenta/patología , Embarazo , Síndrome de Respuesta Inflamatoria Sistémica/sangre , Síndrome de Respuesta Inflamatoria Sistémica/diagnósticoRESUMEN
This review aimed to examine the existing evidence about interventions proposed for the treatment of clinical chorioamnionitis, with the goal of developing an evidence-based contemporary approach for the management of this condition. Most trials that assessed the use of antibiotics in clinical chorioamnionitis included patients with a gestational age of ≥34 weeks and in labor. The first-line antimicrobial regimen for the treatment of clinical chorioamnionitis is ampicillin combined with gentamicin, which should be initiated during the intrapartum period. In the event of a cesarean delivery, patients should receive clindamycin at the time of umbilical cord clamping. The administration of additional antibiotic therapy does not appear to be necessary after vaginal or cesarean delivery. However, if postdelivery antibiotics are prescribed, there is support for the administration of an additional dose. Patients can receive antipyretic agents, mainly acetaminophen, even though there is no clear evidence of their benefits. Current evidence suggests that the administration of antenatal corticosteroids for fetal lung maturation and of magnesium sulfate for fetal neuroprotection to patients with clinical chorioamnionitis between 24 0/7 and 33 6/7 weeks of gestation, and possibly between 23 0/7 and 23 6/7 weeks of gestation, has an overall beneficial effect on the infant. However, delivery should not be delayed to complete the full course of corticosteroids and magnesium sulfate. Once the diagnosis of clinical chorioamnionitis has been established, delivery should be considered, regardless of the gestational age. Vaginal delivery is the safer option and cesarean delivery should be reserved for standard obstetrical indications. The time interval between the diagnosis of clinical chorioamnionitis and delivery is not related to most adverse maternal and neonatal outcomes. Patients may require a higher dose of oxytocin to achieve adequate uterine activity or greater uterine activity to effect a given change in cervical dilation. The benefit of using continuous electronic fetal heart rate monitoring in these patients is unclear. We identified the following promising interventions for the management of clinical chorioamnionitis: (1) an antibiotic regimen including ceftriaxone, clarithromycin, and metronidazole that provides coverage against the most commonly identified microorganisms in patients with clinical chorioamnionitis; (2) vaginal cleansing with antiseptic solutions before cesarean delivery with the aim of decreasing the risk of endometritis and, possibly, postoperative wound infection; and (3) antenatal administration of N-acetylcysteine, an antioxidant and antiinflammatory agent, to reduce neonatal morbidity and mortality. Well-powered randomized controlled trials are needed to assess these interventions in patients with clinical chorioamnionitis.
Asunto(s)
Antibacterianos/uso terapéutico , Cesárea/métodos , Corioamnionitis/terapia , Parto Obstétrico/métodos , Edad Gestacional , Acetilcisteína/uso terapéutico , Corticoesteroides/uso terapéutico , Ampicilina/uso terapéutico , Antiinfecciosos Locales/uso terapéutico , Antioxidantes/uso terapéutico , Antipiréticos/uso terapéutico , Ceftriaxona/uso terapéutico , Claritromicina/uso terapéutico , Clindamicina/uso terapéutico , Endometritis/prevención & control , Medicina Basada en la Evidencia , Femenino , Gentamicinas/uso terapéutico , Humanos , Sulfato de Magnesio/uso terapéutico , Metronidazol/uso terapéutico , Guías de Práctica Clínica como Asunto , Embarazo , Infección Puerperal/prevención & control , Tocolíticos/uso terapéuticoRESUMEN
ETV6-RUNX1 is associated with the most common subtype of childhood leukemia. As few ETV6-RUNX1 carriers develop precursor B-cell acute lymphocytic leukemia (pB-ALL), the underlying genetic basis for development of full-blown leukemia remains to be identified, but the appearance of leukemia cases in time-space clusters keeps infection as a potential causal factor. Here, we present in vivo genetic evidence mechanistically connecting preleukemic ETV6-RUNX1 expression in hematopoetic stem cells/precursor cells (HSC/PC) and postnatal infections for human-like pB-ALL. In our model, ETV6-RUNX1 conferred a low risk of developing pB-ALL after exposure to common pathogens, corroborating the low incidence observed in humans. Murine preleukemic ETV6-RUNX1 pro/preB cells showed high Rag1/2 expression, known for human ETV6-RUNX1 pB-ALL. Murine and human ETV6-RUNX1 pB-ALL revealed recurrent genomic alterations, with a relevant proportion affecting genes of the lysine demethylase (KDM) family. KDM5C loss of function resulted in increased levels of H3K4me3, which coprecipitated with RAG2 in a human cell line model, laying the molecular basis for recombination activity. We conclude that alterations of KDM family members represent a disease-driving mechanism and an explanation for RAG off-target cleavage observed in humans. Our results explain the genetic basis for clonal evolution of an ETV6-RUNX1 preleukemic clone to pB-ALL after infection exposure and offer the possibility of novel therapeutic approaches. Cancer Res; 77(16); 4365-77. ©2017 AACR.
Asunto(s)
Subunidad alfa 2 del Factor de Unión al Sitio Principal/metabolismo , Histona Demetilasas/metabolismo , Proteínas de Fusión Oncogénica/metabolismo , Leucemia-Linfoma Linfoblástico de Células Precursoras B/metabolismo , Leucemia-Linfoma Linfoblástico de Células Precursoras B/microbiología , Animales , Subunidad alfa 2 del Factor de Unión al Sitio Principal/biosíntesis , Subunidad alfa 2 del Factor de Unión al Sitio Principal/genética , Modelos Animales de Enfermedad , Células Madre Hematopoyéticas , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Ratones Transgénicos , Proteínas de Fusión Oncogénica/biosíntesis , Proteínas de Fusión Oncogénica/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras B/genéticaRESUMEN
OBJECTIVES: to estimate the prevalence of Burnout Syndrome and the sleep patterns alterations experienced by health workers who work in an Assisted Residence for the Elderly. MATERIAL AND METHODS: descriptive and cross-sectional research using the Maslach Burnout Inventory and the Sleepiness Epworth scales in a self questionnaire that was aimed to 150 employees at the institution. We used descriptive and inferential statistics with a 95% confidence interval. The relationship between categorical variables was carried out using the non-parametric Mann-Whitney test. RESULTS AND CONCLUSIONS: response rate of 92% (138) on the total respondents (150). The burnout prevalence rate is located at 21.7% with a high percentage of workers with low personal fulfillment (64.1%). There is also a slight tendency to suffer from daytime sleepiness in general. It is worth highlighting musculoskeletal problems as the main physiological conditions in relation to the type of work (70.3%), being coffee as the most consumed substance of those polled. High level prevalence of burnout syndrome in the population studied, especially among the nursing staff and the need to develop interventions to reduce them.
Asunto(s)
Instituciones de Vida Asistida , Agotamiento Profesional/epidemiología , Disomnias/epidemiología , Personal de Salud , Hogares para Ancianos , Enfermedades Profesionales/epidemiología , Adulto , Anciano , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Síndrome , Adulto JovenRESUMEN
OBJECTIVE: To evaluate the influence of overweight, waist circumference, age, gender, and insulin resistance as risk factors for hyperleptinemia. RESEARCH METHODS AND PROCEDURES: A cross-sectional study was carried out in a population of 197 subjects: 59 men (21 aged < 60 years and 38 aged > or =60 years) and 138 women (37 aged < 60 years and 101 aged > or =60 years). The groups were stratified by overweight and normal weight. After a 12-hour fasting period, we measured serum leptin and insulin levels with radioimmunoassay methods. We also measured serum glucose and lipid profile. The data were analyzed by means of comparative tests. A variance-stabilizing transformation (natural logarithmic) was used to meet multiple linear regression, analysis of covariance, and logistic regression models. RESULTS: The leptin serum levels were higher and statistically significant in young and older women than they were in men. We observed an interaction between gender and body mass index to explain the difference in leptin levels (p < 0.0001). Our study demonstrated an inverse relationship between leptin with age and high-density lipoprotein cholesterol. In logistic regression analysis, the overweight x gender interaction and waist circumference have a statistically significant influence as independent variables on hyperleptinemia (overweight x gender odds ratio = 6.81; 95% confidence interval, 1.10 to 46.86; p < 0.05 and waist circumference odds ratio = 4.34; 95% confidence interval, 1.47 to 12.83; p = 0.001). DISCUSSION: Women who were overweight or had a higher waist circumference (women > or = 88 cm and men > or = 102 cm) have a significantly higher risk of having hyperleptinemia. The increase in age as an isolated variable is not a risk factor for hyperleptinemia.
Asunto(s)
Factores de Edad , Constitución Corporal , Peso Corporal , Resistencia a la Insulina , Leptina/sangre , Factores Sexuales , Índice de Masa Corporal , Estudios Transversales , Femenino , Humanos , Modelos Lineales , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Factores de RiesgoRESUMEN
El desarrollo de la Gereontología en México es incipiente, de ahí que no existan valores de referencia confiables de pruebas bioquímicas y hematológicas para la población senecta. Por tal motivo, se determinaron los valores de laboratorio de: biometría hemática y pruebas rutinarias bioquímicas, lípidos, electrolitos, proteínas totales, albúmina, bilirrubina total y conjugada, aspartato-aminotransferasa (AST), alanino-aminotransferasa (ALT), gama-glutamiltransferasa (GGT) y pseudocolinesterasa (CHS) séricos, en dos grupos de 400 individuos clínicamente sanos de ambos sexos y bajo nivel socioeconómico de la ciudad de México, uno de mayores de 60 años y otro de adultos entre 25 y 45 años. Se utilizaron métodos manuales estandarizados para realizar las pruebas. Los intervalos fueron determinados por el cálculo de la mediana y el percentil central 95 con la prueba de Tukey. Los resultados en la fórmula roja para los senectos muestran disminución en los límites inferiores de los intervalos, siendo estadísticamente significativo (p < 0,05) comparando con los adultos jóvenes. Para las pruebas bioquímicas, se encontraron valores altos estadísticamente significativos (p < 0,05) en ácido úrico, colestrol, cLDL y triglicéridos, y bajos en cHDL, proteínas totales, albúmina y fosfato. Se concluye que en la población senecta mexicana algunos analitos se ven afectados por la edad, a diferencia de lo reportado para la población anglosajona